Transitional Cell Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy [NA]
A clinical trial at Thomas Jefferson University is evaluating postoperative outcomes of ureteral stent use versus stent-free radical cystect…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study [Phase 2]
This update describes an open-label, randomized Phase 2 trial evaluating toripalimab with or without sequential intravesical gemcitabine-mit…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood [NA]
A clinical trial update describing quantification of circulating tumor cells during TURBT and PKVBT for transitional cell carcinoma of the u…
-
CLINICAL_TRIALS research · 2014-03-13Clinical Trial Update: Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer
This completed clinical trial update describes the lymph node processing protocol used during radical cystectomy and pelvic lymph node disse…
-
CLINICAL_TRIALS research · 2010-10-07Clinical Trial Update: The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma
This clinical trial update reports on the expression and potential effects of Cyr61 in urinary tract transitional cell carcinoma, reflecting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.